SIMILAR PATTERNS OF AMINO ACIDS FOR 2QM9_B_TDZB202

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ftp MUSCLE FATTY ACID
BINDING PROTEIN

(Schistocerca
gregaria) 		PF00061
(Lipocalin) 		8 PHE A  17
TYR A  20
VAL A  26
SER A  55
THR A  62
ILE A 106
ARG A 128
TYR A 130
 None
 0.94A 2qm9B-1ftpA:
20.5		 2qm9B-1ftpA:
37.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hlg LIPASE, GASTRIC

(Homo sapiens) 		PF00561
(Abhydrolase_1) 		5 PHE A  62
TYR A 149
THR A  34
ALA A 133
ILE A 158
 None
 1.31A 2qm9B-1hlgA:
undetectable		 2qm9B-1hlgA:
16.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1irx LYSYL-TRNA
SYNTHETASE

(Pyrococcus
horikoshii) 		PF01921
(tRNA-synt_1f) 		5 PHE A 431
VAL A 421
SER A 509
SER A 505
ARG A 418
 None
 1.24A 2qm9B-1irxA:
undetectable		 2qm9B-1irxA:
15.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1jjx BRAIN-TYPE FATTY
ACID BINDING PROTEIN

(Homo sapiens) 		PF00061
(Lipocalin) 		6 PHE A  16
TYR A  19
VAL A  25
SER A  55
ARG A  78
TYR A 128
 None
 1.03A 2qm9B-1jjxA:
22.5		 2qm9B-1jjxA:
55.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1jjx BRAIN-TYPE FATTY
ACID BINDING PROTEIN

(Homo sapiens) 		PF00061
(Lipocalin) 		7 PHE A  16
TYR A  19
VAL A  25
THR A  60
ALA A  75
ARG A  78
TYR A 128
 None
 1.06A 2qm9B-1jjxA:
22.5		 2qm9B-1jjxA:
55.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1k8q TRIACYLGLYCEROL
LIPASE, GASTRIC

(Canis lupus) 		PF00561
(Abhydrolase_1) 		5 PHE A  62
TYR A 149
THR A  34
ALA A 133
ILE A 158
 None
 1.23A 2qm9B-1k8qA:
undetectable		 2qm9B-1k8qA:
18.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mt5 FATTY-ACID AMIDE
HYDROLASE

(Rattus
norvegicus) 		PF01425
(Amidase) 		5 PHE A 363
TYR A 330
VAL A 552
SER A 457
ILE A 368
 None
 1.30A 2qm9B-1mt5A:
undetectable		 2qm9B-1mt5A:
12.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nw5 MODIFICATION
METHYLASE RSRI

(Rhodobacter
sphaeroides) 		PF01555
(N6_N4_Mtase) 		5 VAL A  95
ALA A  90
ILE A 104
CYH A  64
TYR A  81
 None
 1.42A 2qm9B-1nw5A:
undetectable		 2qm9B-1nw5A:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1o8v FATTY ACID BINDING
PROTEIN HOMOLOG

(Echinococcus
granulosus) 		PF00061
(Lipocalin) 		5 PHE A  16
VAL A  25
SER A  54
ARG A  79
ARG A 127
 PLM  A1136 (-4.7A)
None
PLM  A1136 ( 4.9A)
PLM  A1136 (-4.6A)
PLM  A1136 (-4.4A)
 1.13A 2qm9B-1o8vA:
24.2		 2qm9B-1o8vA:
36.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1o8v FATTY ACID BINDING
PROTEIN HOMOLOG

(Echinococcus
granulosus) 		PF00061
(Lipocalin) 		8 PHE A  16
VAL A  25
SER A  54
SER A  56
THR A  61
ARG A  79
ARG A 127
TYR A 129
 PLM  A1136 (-4.7A)
None
PLM  A1136 ( 4.9A)
PLM  A1136 ( 3.8A)
None
PLM  A1136 (-4.6A)
PLM  A1136 (-4.4A)
PLM  A1136 (-4.6A)
 0.58A 2qm9B-1o8vA:
24.2		 2qm9B-1o8vA:
36.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1o8v FATTY ACID BINDING
PROTEIN HOMOLOG

(Echinococcus
granulosus) 		PF00061
(Lipocalin) 		8 PHE A  16
VAL A  25
SER A  54
SER A  56
THR A  61
ILE A 105
ARG A 127
TYR A 129
 PLM  A1136 (-4.7A)
None
PLM  A1136 ( 4.9A)
PLM  A1136 ( 3.8A)
None
None
PLM  A1136 (-4.4A)
PLM  A1136 (-4.6A)
 0.65A 2qm9B-1o8vA:
24.2		 2qm9B-1o8vA:
36.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ot5 KEXIN

(Saccharomyces
cerevisiae) 		PF00082
(Peptidase_S8)
PF01483
(P_proprotein) 		5 VAL A 234
SER A 272
ALA A 391
ILE A 339
TYR A 348
 None
 1.29A 2qm9B-1ot5A:
undetectable		 2qm9B-1ot5A:
16.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1pmp P2 MYELIN PROTEIN

(Bos taurus) 		PF00061
(Lipocalin) 		11 PHE A  16
TYR A  19
VAL A  25
SER A  55
THR A  60
ALA A  75
ARG A  78
ILE A 104
CYH A 117
ARG A 126
TYR A 128
 OLA  A 200 ( 4.8A)
None
None
OLA  A 200 ( 4.3A)
None
OLA  A 200 ( 4.0A)
None
None
OLA  A 200 ( 4.4A)
OLA  A 200 (-3.9A)
OLA  A 200 (-4.7A)
 0.56A 2qm9B-1pmpA:
25.1		 2qm9B-1pmpA:
63.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qyi HYPOTHETICAL PROTEIN

(Staphylococcus
aureus) 		PF13242
(Hydrolase_like) 		5 TYR A 148
SER A  22
THR A  25
ALA A 177
ILE A  83
 None
 1.48A 2qm9B-1qyiA:
undetectable		 2qm9B-1qyiA:
17.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1tow FATTY ACID-BINDING
PROTEIN, ADIPOCYTE

(Homo sapiens) 		PF00061
(Lipocalin) 		12 PHE A  16
TYR A  19
VAL A  25
SER A  53
SER A  55
THR A  60
ALA A  75
ARG A  78
ILE A 104
CYH A 117
ARG A 126
TYR A 128
 CRZ  A 501 (-4.5A)
None
None
CRZ  A 501 ( 3.8A)
CRZ  A 501 ( 4.8A)
None
CRZ  A 501 ( 3.8A)
CRZ  A 501 (-4.7A)
CRZ  A 501 ( 4.8A)
CRZ  A 501 ( 3.8A)
CRZ  A 501 (-3.8A)
CRZ  A 501 (-4.8A)
 0.48A 2qm9B-1towA:
26.2		 2qm9B-1towA:
91.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1tow FATTY ACID-BINDING
PROTEIN, ADIPOCYTE

(Homo sapiens) 		PF00061
(Lipocalin) 		7 PHE A  16
VAL A  23
SER A  53
THR A  60
ALA A  75
ARG A 126
TYR A 128
 CRZ  A 501 (-4.5A)
None
CRZ  A 501 ( 3.8A)
None
CRZ  A 501 ( 3.8A)
CRZ  A 501 (-3.8A)
CRZ  A 501 (-4.8A)
 1.27A 2qm9B-1towA:
26.2		 2qm9B-1towA:
91.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g7u TRANSCRIPTIONAL
REGULATOR

(Rhodococcus
jostii) 		PF01614
(IclR)
PF09339
(HTH_IclR) 		5 PHE A 233
VAL A  95
SER A 141
ALA A 220
ILE A 127
 None
 1.38A 2qm9B-2g7uA:
undetectable		 2qm9B-2g7uA:
19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2go7 HYDROLASE, HALOACID
DEHALOGENASE-LIKE
FAMILY

(Streptococcus
pneumoniae) 		PF13419
(HAD_2) 		5 VAL A  83
SER A 132
THR A 131
ALA A 113
ARG A  72
 None
None
None
None
CL  A 209 (-4.2A)
 1.39A 2qm9B-2go7A:
undetectable		 2qm9B-2go7A:
21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ola O-SUCCINYLBENZOIC
ACID SYNTHETASE

(Staphylococcus
aureus) 		PF13378
(MR_MLE_C) 		5 PHE A  51
TYR A  56
THR A 282
ARG A 246
TYR A 301
 None
 1.40A 2qm9B-2olaA:
undetectable		 2qm9B-2olaA:
19.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2q9s FATTY ACID-BINDING
PROTEIN

(Mus musculus) 		PF00061
(Lipocalin) 		12 PHE A  16
TYR A  19
VAL A  25
SER A  53
SER A  55
THR A  60
ALA A  75
ARG A  78
ILE A 104
CYH A 117
ARG A 126
TYR A 128
 None
None
None
EIC  A 601 (-3.1A)
None
None
EIC  A 601 ( 4.1A)
EIC  A 601 ( 4.9A)
EIC  A 601 ( 4.5A)
EIC  A 601 (-3.3A)
EIC  A 601 (-4.5A)
EIC  A 601 (-4.7A)
 0.34A 2qm9B-2q9sA:
27.3		 2qm9B-2q9sA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2q9s FATTY ACID-BINDING
PROTEIN

(Mus musculus) 		PF00061
(Lipocalin) 		7 PHE A  16
VAL A  23
SER A  53
THR A  60
ALA A  75
ARG A 126
TYR A 128
 None
None
EIC  A 601 (-3.1A)
None
EIC  A 601 ( 4.1A)
EIC  A 601 (-4.5A)
EIC  A 601 (-4.7A)
 1.33A 2qm9B-2q9sA:
27.3		 2qm9B-2q9sA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yxe PROTEIN-L-ISOASPARTA
TE
O-METHYLTRANSFERASE

(Methanocaldococcus
jannaschii) 		PF01135
(PCMT) 		5 VAL A  32
SER A 107
THR A 153
ARG A  34
ILE A  54
 None
 1.14A 2qm9B-2yxeA:
undetectable		 2qm9B-2yxeA:
23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h1v GLUCOKINASE

(Homo sapiens) 		PF00349
(Hexokinase_1)
PF03727
(Hexokinase_2) 		5 PHE X 423
VAL X 408
THR X 255
ALA X 232
ILE X 390
 None
 1.21A 2qm9B-3h1vX:
undetectable		 2qm9B-3h1vX:
18.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hf8 TRYPTOPHAN
5-HYDROXYLASE 1

(Homo sapiens) 		PF00351
(Biopterin_H) 		5 VAL A 316
THR A 225
ALA A 287
ILE A 229
CYH A 252
 None
 1.45A 2qm9B-3hf8A:
undetectable		 2qm9B-3hf8A:
19.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3led 3-OXOACYL-ACYL
CARRIER PROTEIN
SYNTHASE III

(Rhodopseudomonas
palustris) 		PF08541
(ACP_syn_III_C)
PF08545
(ACP_syn_III) 		5 VAL A 268
SER A 126
SER A 158
ALA A 359
ILE A 200
 None
 1.36A 2qm9B-3ledA:
undetectable		 2qm9B-3ledA:
17.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3nr3 PMP2 PROTEIN

(Homo sapiens) 		PF00061
(Lipocalin) 		11 PHE A  17
TYR A  20
VAL A  26
SER A  56
THR A  61
ALA A  76
ARG A  79
ILE A 105
CYH A 118
ARG A 127
TYR A 129
 None
None
None
PLM  A 901 (-3.7A)
None
PLM  A 901 ( 4.0A)
None
PLM  A 901 ( 4.5A)
PLM  A 901 ( 3.8A)
PLM  A 901 (-4.6A)
PLM  A 901 (-4.6A)
 0.63A 2qm9B-3nr3A:
25.6		 2qm9B-3nr3A:
59.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3nr3 PMP2 PROTEIN

(Homo sapiens) 		PF00061
(Lipocalin) 		7 PHE A  17
VAL A  26
SER A  56
ALA A  76
CYH A 125
ARG A 127
TYR A 129
 None
None
PLM  A 901 (-3.7A)
PLM  A 901 ( 4.0A)
None
PLM  A 901 (-4.6A)
PLM  A 901 (-4.6A)
 1.49A 2qm9B-3nr3A:
25.6		 2qm9B-3nr3A:
59.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3nr3 PMP2 PROTEIN

(Homo sapiens) 		PF00061
(Lipocalin) 		5 TYR A  20
VAL A  26
THR A  54
ARG A  79
ILE A 105
 None
None
PLM  A 901 ( 4.6A)
None
PLM  A 901 ( 4.5A)
 1.22A 2qm9B-3nr3A:
25.6		 2qm9B-3nr3A:
59.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3pp6 SODIUM-CALCIUM
EXCHANGER

(Doryteuthis
pealeii) 		PF00061
(Lipocalin) 		6 PHE A  17
TYR A  20
VAL A  26
THR A  61
ARG A  79
ARG A 126
 None
None
None
PAM  A 133 (-3.7A)
None
PAM  A 133 (-3.9A)
 0.43A 2qm9B-3pp6A:
23.8		 2qm9B-3pp6A:
37.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3wbg FATTY ACID-BINDING
PROTEIN, HEART

(Homo sapiens) 		PF00061
(Lipocalin) 		9 PHE A  16
TYR A  19
VAL A  25
SER A  55
THR A  60
ALA A  75
ARG A  78
ARG A 126
TYR A 128
 2AN  A 201 ( 4.9A)
2AN  A 201 (-4.8A)
None
2AN  A 201 (-3.2A)
None
2AN  A 201 ( 3.8A)
2AN  A 201 ( 4.8A)
2AN  A 201 ( 4.9A)
None
 0.62A 2qm9B-3wbgA:
25.5		 2qm9B-3wbgA:
58.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3wbg FATTY ACID-BINDING
PROTEIN, HEART

(Homo sapiens) 		PF00061
(Lipocalin) 		5 VAL A  25
SER A  55
ALA A  75
CYH A 124
TYR A 128
 None
2AN  A 201 (-3.2A)
2AN  A 201 ( 3.8A)
None
None
 1.21A 2qm9B-3wbgA:
25.5		 2qm9B-3wbgA:
58.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zfv CRISPR-ASSOCIATED
ENDORIBONUCLEASE
CAS6 1

(Sulfolobus
solfataricus) 		PF10040
(CRISPR_Cas6) 		5 VAL A 128
SER A 204
SER A 208
ALA A 253
ARG A 255
 None
 1.45A 2qm9B-3zfvA:
undetectable		 2qm9B-3zfvA:
20.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zif HEXON PROTEIN

(Bovine
mastadenovirus
B) 		PF01065
(Adeno_hexon)
PF03678
(Adeno_hexon_C) 		5 SER A 218
THR A 265
ALA A 286
ILE A 454
ARG A 276
 None
 1.43A 2qm9B-3zifA:
undetectable		 2qm9B-3zifA:
11.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4a60 FATTY ACID-BINDING
PROTEIN 9 TESTIS
LIPID-BINDING
PROTEIN, TLBP,
TESTIS-TYPE FATTY
ACID-BINDING
PROTEIN, T-FABP

(Homo sapiens) 		PF00061
(Lipocalin) 		11 PHE A  17
TYR A  20
VAL A  26
SER A  56
THR A  61
ALA A  76
ARG A  79
ILE A 105
CYH A 118
ARG A 127
TYR A 129
 None
None
None
NA  A1132 (-2.9A)
None
EDO  A1134 ( 3.9A)
EDO  A1134 ( 4.9A)
None
None
None
None
 0.74A 2qm9B-4a60A:
24.4		 2qm9B-4a60A:
55.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4a60 FATTY ACID-BINDING
PROTEIN 9 TESTIS
LIPID-BINDING
PROTEIN, TLBP,
TESTIS-TYPE FATTY
ACID-BINDING
PROTEIN, T-FABP

(Homo sapiens) 		PF00061
(Lipocalin) 		5 TYR A  20
VAL A  26
THR A  54
ARG A  79
ILE A 105
 None
None
None
EDO  A1134 ( 4.9A)
None
 1.22A 2qm9B-4a60A:
24.4		 2qm9B-4a60A:
55.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4azn FATTY ACID-BINDING
PROTEIN, EPIDERMAL

(Mus musculus) 		PF00061
(Lipocalin) 		10 PHE A  19
TYR A  22
VAL A  28
THR A  63
ALA A  78
ARG A  81
ILE A 107
CYH A 120
ARG A 129
TYR A 131
 None
 0.74A 2qm9B-4aznA:
23.3		 2qm9B-4aznA:
47.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4azn FATTY ACID-BINDING
PROTEIN, EPIDERMAL

(Mus musculus) 		PF00061
(Lipocalin) 		5 TYR A  22
SER A  58
THR A  63
ALA A  78
ILE A 107
 None
 0.90A 2qm9B-4aznA:
23.3		 2qm9B-4aznA:
47.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4azp FATTY ACID-BINDING
PROTEIN, EPIDERMAL

(Mus musculus) 		PF00061
(Lipocalin) 		11 PHE A  19
TYR A  22
VAL A  28
SER A  58
THR A  63
ALA A  78
ARG A  81
ILE A 107
CYH A 120
ARG A 129
TYR A 131
 None
None
None
A9M  A1136 ( 4.1A)
None
A9M  A1136 (-3.5A)
None
A9M  A1136 (-4.4A)
A9M  A1136 ( 3.8A)
A9M  A1136 (-4.3A)
A9M  A1136 (-4.8A)
 0.50A 2qm9B-4azpA:
25.0		 2qm9B-4azpA:
48.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4azp FATTY ACID-BINDING
PROTEIN, EPIDERMAL

(Mus musculus) 		PF00061
(Lipocalin) 		5 TYR A  22
VAL A  28
THR A  56
ARG A  81
ILE A 107
 None
None
A9M  A1136 ( 4.3A)
None
A9M  A1136 (-4.4A)
 1.22A 2qm9B-4azpA:
25.0		 2qm9B-4azpA:
48.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4azp FATTY ACID-BINDING
PROTEIN, EPIDERMAL

(Mus musculus) 		PF00061
(Lipocalin) 		5 VAL A  28
SER A  58
ALA A  78
CYH A 127
TYR A 131
 None
A9M  A1136 ( 4.1A)
A9M  A1136 (-3.5A)
None
A9M  A1136 (-4.8A)
 1.22A 2qm9B-4azpA:
25.0		 2qm9B-4azpA:
48.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4i3c BILIRUBIN-INDUCIBLE
FLUORESCENT PROTEIN
UNAG

(Anguilla
japonica) 		PF00061
(Lipocalin) 		6 PHE A  17
TYR A  20
THR A  65
ARG A  83
ARG A 132
TYR A 134
 BLR  A 200 (-3.6A)
None
BLR  A 200 ( 4.0A)
None
BLR  A 200 (-3.5A)
None
 0.87A 2qm9B-4i3cA:
22.0		 2qm9B-4i3cA:
40.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jeu SYNTAXIN-BINDING
PROTEIN 1

(Rattus
norvegicus) 		PF00995
(Sec1) 		5 TYR A 145
VAL A 545
THR A 557
ALA A 553
ILE A 538
 None
 1.41A 2qm9B-4jeuA:
undetectable		 2qm9B-4jeuA:
14.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4nns FATTY ACID-BINDING
PROTEIN, ADIPOCYTE

(Homo sapiens) 		PF00061
(Lipocalin) 		12 PHE A  16
TYR A  19
VAL A  25
SER A  53
SER A  55
THR A  60
ALA A  75
ARG A  78
ILE A 104
CYH A 117
ARG A 126
TYR A 128
 None
None
None
75D  A 201 (-2.5A)
75D  A 201 ( 4.7A)
None
75D  A 201 (-3.6A)
75D  A 201 (-4.7A)
75D  A 201 ( 4.4A)
75D  A 201 (-3.5A)
75D  A 201 (-3.9A)
None
 0.38A 2qm9B-4nnsA:
26.6		 2qm9B-4nnsA:
81.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4nns FATTY ACID-BINDING
PROTEIN, ADIPOCYTE

(Homo sapiens) 		PF00061
(Lipocalin) 		6 PHE A  16
VAL A  23
SER A  53
THR A  60
ARG A 126
TYR A 128
 None
None
75D  A 201 (-2.5A)
None
75D  A 201 (-3.9A)
None
 1.22A 2qm9B-4nnsA:
26.6		 2qm9B-4nnsA:
81.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b29 FATTY ACID-BINDING
PROTEIN, HEART

(Homo sapiens) 		PF00061
(Lipocalin) 		8 TYR A  19
VAL A  25
SER A  55
THR A  60
ALA A  75
ARG A  78
ARG A 126
TYR A 128
 None
None
PLM  A 200 ( 4.1A)
PLM  A 200 ( 4.8A)
PLM  A 200 ( 4.0A)
None
PLM  A 200 (-3.7A)
PLM  A 200 (-4.8A)
 0.51A 2qm9B-5b29A:
25.3		 2qm9B-5b29A:
62.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b29 FATTY ACID-BINDING
PROTEIN, HEART

(Homo sapiens) 		PF00061
(Lipocalin) 		5 VAL A  25
SER A  55
ALA A  75
CYH A 124
TYR A 128
 None
PLM  A 200 ( 4.1A)
PLM  A 200 ( 4.0A)
None
PLM  A 200 (-4.8A)
 1.23A 2qm9B-5b29A:
25.3		 2qm9B-5b29A:
62.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5bvq FATTY ACID-BINDING
PROTEIN

(Pygoscelis
papua) 		PF00061
(Lipocalin) 		6 PHE A  17
TYR A  20
VAL A  26
THR A  54
ILE A 105
CYH A 118
 None
 1.02A 2qm9B-5bvqA:
24.2		 2qm9B-5bvqA:
73.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5bvq FATTY ACID-BINDING
PROTEIN

(Pygoscelis
papua) 		PF00061
(Lipocalin) 		9 PHE A  17
TYR A  20
VAL A  26
THR A  61
ALA A  76
ARG A  79
ILE A 105
CYH A 118
TYR A 129
 None
 0.41A 2qm9B-5bvqA:
24.2		 2qm9B-5bvqA:
73.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5bvq FATTY ACID-BINDING
PROTEIN

(Pygoscelis
papua) 		PF00061
(Lipocalin) 		6 PHE A  17
VAL A  26
THR A  61
ALA A  76
ARG A 127
TYR A 129
 None
 1.38A 2qm9B-5bvqA:
24.2		 2qm9B-5bvqA:
73.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5bvt EPIDERMAL FATTY
ACID-BINDING PROTEIN

(Pygoscelis
papua) 		PF00061
(Lipocalin) 		5 PHE A  19
TYR A  22
SER A  63
ILE A 108
CYH A 121
 PAM  A 201 ( 4.9A)
None
None
PAM  A 201 ( 4.7A)
PAM  A 201 ( 4.0A)
 1.25A 2qm9B-5bvtA:
25.2		 2qm9B-5bvtA:
47.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5bvt EPIDERMAL FATTY
ACID-BINDING PROTEIN

(Pygoscelis
papua) 		PF00061
(Lipocalin) 		9 PHE A  19
TYR A  22
VAL A  28
SER A  58
ARG A  81
ILE A 108
CYH A 121
ARG A 130
TYR A 132
 PAM  A 201 ( 4.9A)
None
None
PAM  A 201 ( 3.9A)
None
PAM  A 201 ( 4.7A)
PAM  A 201 ( 4.0A)
PAM  A 201 ( 4.6A)
None
 0.49A 2qm9B-5bvtA:
25.2		 2qm9B-5bvtA:
47.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5bvt EPIDERMAL FATTY
ACID-BINDING PROTEIN

(Pygoscelis
papua) 		PF00061
(Lipocalin) 		6 TYR A  22
VAL A  28
THR A  56
ARG A  81
ILE A 108
CYH A 121
 None
None
None
None
PAM  A 201 ( 4.7A)
PAM  A 201 ( 4.0A)
 0.97A 2qm9B-5bvtA:
25.2		 2qm9B-5bvtA:
47.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fav CHOLINE
TRIMETHYLAMINE-LYASE

(Desulfovibrio
alaskensis) 		PF01228
(Gly_radical)
PF02901
(PFL-like) 		5 PHE A 545
TYR A 542
VAL A 626
ALA A 714
ILE A 671
 None
 1.17A 2qm9B-5favA:
undetectable		 2qm9B-5favA:
11.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5gkb FATTY ACID BINDIN
PROTEIN, ISOFORM B

(Drosophila
melanogaster) 		PF00061
(Lipocalin) 		7 PHE A  16
TYR A  19
VAL A  25
SER A  55
ILE A 103
ARG A 125
TYR A 127
 None
 0.72A 2qm9B-5gkbA:
21.1		 2qm9B-5gkbA:
42.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5hz5 FATTY ACID-BINDING
PROTEIN, EPIDERMAL

(Homo sapiens) 		PF00061
(Lipocalin) 		10 PHE A  19
TYR A  22
VAL A  28
SER A  58
THR A  63
ALA A  78
ARG A  81
ILE A 107
ARG A 129
TYR A 131
 65X  A 203 ( 4.7A)
65X  A 203 ( 4.7A)
None
65X  A 203 ( 3.7A)
65X  A 203 ( 4.8A)
65X  A 203 (-3.5A)
None
65X  A 203 (-3.9A)
65X  A 203 (-3.9A)
None
 0.59A 2qm9B-5hz5A:
24.6		 2qm9B-5hz5A:
47.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5l9w ACETOPHENONE
CARBOXYLASE BETA
SUBUNIT
ACETOPHENONE
CARBOXYLASE DELTA
SUBUNIT

(Aromatoleum
aromaticum) 		PF02538
(Hydantoinase_B)
PF08882
(Acetone_carb_G) 		5 TYR C  36
VAL C  99
SER A 388
ALA A 378
TYR A 586
 None
 1.28A 2qm9B-5l9wC:
undetectable		 2qm9B-5l9wC:
22.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uwz ALDEHYDE
DECARBONYLASE

(Gloeobacter
violaceus) 		no annotation 5 PHE A  88
TYR A  87
VAL A 178
ALA A 119
ILE A  25
 EDO  A 301 ( 4.7A)
None
None
STE  A 303 (-3.1A)
STE  A 303 (-4.2A)
 1.08A 2qm9B-5uwzA:
undetectable		 2qm9B-5uwzA:
18.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1o8v FATTY ACID BINDING
PROTEIN HOMOLOG

(Echinococcus
granulosus) 		PF00061
(Lipocalin) 		4 MET A  20
PRO A  38
ASP A  77
ARG A 107
 PLM  A1136 (-3.5A)
None
PLM  A1136 (-3.8A)
PLM  A1136 (-3.9A)
 0.48A 2qm9B-1o8vA:
24.2		 2qm9B-1o8vA:
36.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1pmp P2 MYELIN PROTEIN

(Bos taurus) 		PF00061
(Lipocalin) 		4 MET A  20
PRO A  38
ASP A  76
ARG A 106
 OLA  A 200 (-4.6A)
None
OLA  A 200 ( 4.7A)
OLA  A 200 (-3.2A)
 0.79A 2qm9B-1pmpA:
25.1		 2qm9B-1pmpA:
63.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1tow FATTY ACID-BINDING
PROTEIN, ADIPOCYTE

(Homo sapiens) 		PF00061
(Lipocalin) 		4 MET A  20
PRO A  38
ASP A  76
ARG A 106
 CRZ  A 501 ( 3.8A)
CRZ  A 501 (-4.5A)
CRZ  A 501 (-4.0A)
None
 0.32A 2qm9B-1towA:
26.2		 2qm9B-1towA:
91.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2q9s FATTY ACID-BINDING
PROTEIN

(Mus musculus) 		PF00061
(Lipocalin) 		4 MET A  20
PRO A  38
ASP A  76
ARG A 106
 EIC  A 601 ( 4.1A)
EIC  A 601 (-4.6A)
EIC  A 601 (-3.6A)
None
 0.13A 2qm9B-2q9sA:
27.3		 2qm9B-2q9sA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3nr3 PMP2 PROTEIN

(Homo sapiens) 		PF00061
(Lipocalin) 		4 MET A  21
PRO A  39
ASP A  77
ARG A 107
 PLM  A 901 (-3.7A)
SO4  A 903 ( 4.8A)
PLM  A 901 (-4.0A)
PLM  A 901 (-3.7A)
 0.41A 2qm9B-3nr3A:
25.6		 2qm9B-3nr3A:
59.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3pp6 SODIUM-CALCIUM
EXCHANGER

(Doryteuthis
pealeii) 		PF00061
(Lipocalin) 		4 MET A  21
PRO A  39
ASP A  77
ARG A 106
 PAM  A 133 ( 3.9A)
PAM  A 133 (-4.4A)
PAM  A 133 (-4.3A)
None
 0.39A 2qm9B-3pp6A:
23.8		 2qm9B-3pp6A:
37.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3wbg FATTY ACID-BINDING
PROTEIN, HEART

(Homo sapiens) 		PF00061
(Lipocalin) 		4 MET A  20
PRO A  38
ASP A  76
ARG A 106
 2AN  A 201 ( 3.9A)
2AN  A 201 ( 4.3A)
2AN  A 201 (-3.9A)
None
 0.51A 2qm9B-3wbgA:
25.5		 2qm9B-3wbgA:
58.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4a60 FATTY ACID-BINDING
PROTEIN 9 TESTIS
LIPID-BINDING
PROTEIN, TLBP,
TESTIS-TYPE FATTY
ACID-BINDING
PROTEIN, T-FABP

(Homo sapiens) 		PF00061
(Lipocalin) 		4 MET A  21
PRO A  39
ASP A  77
ARG A 107
 EDO  A1134 (-4.5A)
None
EDO  A1134 (-3.7A)
None
 0.88A 2qm9B-4a60A:
24.4		 2qm9B-4a60A:
55.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4azp FATTY ACID-BINDING
PROTEIN, EPIDERMAL

(Mus musculus) 		PF00061
(Lipocalin) 		4 MET A  23
PRO A  41
ASP A  79
ARG A 109
 A9M  A1136 (-3.7A)
A9M  A1136 ( 4.7A)
A9M  A1136 (-4.0A)
None
 0.52A 2qm9B-4azpA:
25.0		 2qm9B-4azpA:
48.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4nns FATTY ACID-BINDING
PROTEIN, ADIPOCYTE

(Homo sapiens) 		PF00061
(Lipocalin) 		4 MET A  20
PRO A  38
ASP A  76
ARG A 106
 75D  A 201 (-3.6A)
75D  A 201 (-4.4A)
75D  A 201 (-4.1A)
75D  A 201 ( 4.6A)
 0.26A 2qm9B-4nnsA:
26.6		 2qm9B-4nnsA:
81.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5af7 ACYL-COA
DEHYDROGENASE

(Advenella
mimigardefordensis) 		PF00441
(Acyl-CoA_dh_1)
PF02770
(Acyl-CoA_dh_M)
PF02771
(Acyl-CoA_dh_N) 		4 MET A  50
PRO A  37
ASP A 117
ARG A  84
 None
None
None
FAD  A 410 (-3.7A)
 1.40A 2qm9B-5af7A:
undetectable		 2qm9B-5af7A:
17.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b29 FATTY ACID-BINDING
PROTEIN, HEART

(Homo sapiens) 		PF00061
(Lipocalin) 		4 MET A  20
PRO A  38
ASP A  76
ARG A 106
 PLM  A 200 ( 4.0A)
PLM  A 200 ( 4.9A)
PLM  A 200 ( 4.3A)
None
 0.54A 2qm9B-5b29A:
25.3		 2qm9B-5b29A:
62.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5bvq FATTY ACID-BINDING
PROTEIN

(Pygoscelis
papua) 		PF00061
(Lipocalin) 		4 MET A  21
PRO A  39
ASP A  77
ARG A 107
 None
 0.47A 2qm9B-5bvqA:
24.2		 2qm9B-5bvqA:
73.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5bvt EPIDERMAL FATTY
ACID-BINDING PROTEIN

(Pygoscelis
papua) 		PF00061
(Lipocalin) 		4 MET A  23
PRO A  41
ASP A  79
ARG A 110
 PAM  A 201 ( 3.8A)
PAM  A 201 ( 4.8A)
PAM  A 201 (-4.0A)
PAM  A 201 ( 4.6A)
 0.25A 2qm9B-5bvtA:
25.2		 2qm9B-5bvtA:
47.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5hz5 FATTY ACID-BINDING
PROTEIN, EPIDERMAL

(Homo sapiens) 		PF00061
(Lipocalin) 		4 MET A  23
PRO A  41
ASP A  79
ARG A 109
 65X  A 203 ( 3.9A)
65X  A 203 (-4.4A)
65X  A 203 ( 4.2A)
65X  A 203 (-4.0A)
 0.33A 2qm9B-5hz5A:
24.6		 2qm9B-5hz5A:
47.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xjv DUAL SPECIFICITY
PROTEIN PHOSPHATASE
13 ISOFORM A

(Homo sapiens) 		no annotation 4 MET A 145
PRO A 167
ASP A 179
ARG A 160
 None
 1.13A 2qm9B-5xjvA:
undetectable		 2qm9B-5xjvA:
18.42